Cargando…

Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration

Although 3,3′-iminodipropionitrile (IDPN) is widely used as a neurotoxicant to cause axonopathy due to accumulation of neurofilaments in several rodent models, its mechanism of neurotoxicity has not been fully understood. In particular, no information regarding microRNA (miRNA) alteration associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Keiko, Kushida, Masahiko, Miyata, Kaori, Sumida, Kayo, Takeda, Shuji, Izawa, Takeshi, Kuwamura, Mitsuru, Yamate, Jyoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Toxicologic Pathology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097965/
https://www.ncbi.nlm.nih.gov/pubmed/27821907
http://dx.doi.org/10.1293/tox.2016-0019
_version_ 1782465693336207360
author Ogata, Keiko
Kushida, Masahiko
Miyata, Kaori
Sumida, Kayo
Takeda, Shuji
Izawa, Takeshi
Kuwamura, Mitsuru
Yamate, Jyoji
author_facet Ogata, Keiko
Kushida, Masahiko
Miyata, Kaori
Sumida, Kayo
Takeda, Shuji
Izawa, Takeshi
Kuwamura, Mitsuru
Yamate, Jyoji
author_sort Ogata, Keiko
collection PubMed
description Although 3,3′-iminodipropionitrile (IDPN) is widely used as a neurotoxicant to cause axonopathy due to accumulation of neurofilaments in several rodent models, its mechanism of neurotoxicity has not been fully understood. In particular, no information regarding microRNA (miRNA) alteration associated with IDPN is available. This study was conducted to reveal miRNA alteration related to IDPN-induced neurotoxicity. Rats were administered IDPN (20, 50, or 125 mg/kg/day) orally for 3, 7, and 14 days. Histopathological features were investigated using immunohistochemistry for neurofilaments and glial cells, and miRNA alterations were analyzed by microarray and reverse transcription polymerase chain reaction. Nervous symptoms such as ataxic gait and head bobbing were observed from Day 9 at 125 mg/kg. Axonal swelling due to accumulation of neurofilaments was observed especially in the pons, medulla, and spinal cord on Day 7 at 125 mg/kg and on Day 14 at 50 and 125 mg/kg. Furthermore, significant upregulation of miR-547* was observed in the pons and medulla in treated animals only on Day 14 at 125 mg/kg. This is the first report indicating that miR-547* is associated with IDPN-induced neurotoxicity, especially in an advanced stage of axonopathy.
format Online
Article
Text
id pubmed-5097965
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Japanese Society of Toxicologic Pathology
record_format MEDLINE/PubMed
spelling pubmed-50979652016-11-07 Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration Ogata, Keiko Kushida, Masahiko Miyata, Kaori Sumida, Kayo Takeda, Shuji Izawa, Takeshi Kuwamura, Mitsuru Yamate, Jyoji J Toxicol Pathol Original Article Although 3,3′-iminodipropionitrile (IDPN) is widely used as a neurotoxicant to cause axonopathy due to accumulation of neurofilaments in several rodent models, its mechanism of neurotoxicity has not been fully understood. In particular, no information regarding microRNA (miRNA) alteration associated with IDPN is available. This study was conducted to reveal miRNA alteration related to IDPN-induced neurotoxicity. Rats were administered IDPN (20, 50, or 125 mg/kg/day) orally for 3, 7, and 14 days. Histopathological features were investigated using immunohistochemistry for neurofilaments and glial cells, and miRNA alterations were analyzed by microarray and reverse transcription polymerase chain reaction. Nervous symptoms such as ataxic gait and head bobbing were observed from Day 9 at 125 mg/kg. Axonal swelling due to accumulation of neurofilaments was observed especially in the pons, medulla, and spinal cord on Day 7 at 125 mg/kg and on Day 14 at 50 and 125 mg/kg. Furthermore, significant upregulation of miR-547* was observed in the pons and medulla in treated animals only on Day 14 at 125 mg/kg. This is the first report indicating that miR-547* is associated with IDPN-induced neurotoxicity, especially in an advanced stage of axonopathy. Japanese Society of Toxicologic Pathology 2016-06-03 2016-10 /pmc/articles/PMC5097965/ /pubmed/27821907 http://dx.doi.org/10.1293/tox.2016-0019 Text en ©2016 The Japanese Society of Toxicologic Pathology http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.
spellingShingle Original Article
Ogata, Keiko
Kushida, Masahiko
Miyata, Kaori
Sumida, Kayo
Takeda, Shuji
Izawa, Takeshi
Kuwamura, Mitsuru
Yamate, Jyoji
Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
title Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
title_full Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
title_fullStr Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
title_full_unstemmed Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
title_short Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
title_sort alteration of microrna expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097965/
https://www.ncbi.nlm.nih.gov/pubmed/27821907
http://dx.doi.org/10.1293/tox.2016-0019
work_keys_str_mv AT ogatakeiko alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration
AT kushidamasahiko alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration
AT miyatakaori alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration
AT sumidakayo alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration
AT takedashuji alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration
AT izawatakeshi alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration
AT kuwamuramitsuru alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration
AT yamatejyoji alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration